Cited by 176Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular PreventionDiabetes Treatment and Management

The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.

Cardiovascular risk assessment scores for people with diabetes: a systematic review

Open access

Chamnan, P., Simmons, R. K., Sharp, S. J., Griffin, S. J., Wareham, N. J.·2009·Diabetologia

DOI 10.1007/s00125-009-1454-0PMC PMC2744770

Open this paper in CoChat — free account Open PDF

Abstract

People with type 2 diabetes have an increased risk of cardiovascular disease (CVD). Multivariate cardiovascular risk scores have been used in many countries to identify individuals who are at high risk of CVD. These risk scores include those originally developed in individuals with diabetes and those developed in a general population. This article reviews the published evidence for the performance of CVD risk scores in diabetic patients by: (1) examining the overall rationale for using risk scores; (2) systematically reviewing the literature on available scores; and (3) exploring methodological issues surrounding the development, validation and comparison of risk scores. The predictive performance of cardiovascular risk scores varies substantially between different populations. There is little evidence to suggest that risk scores developed in individuals with diabetes estimate cardiovascular risk more accurately than those developed in the general population. The inconsistency in the methods used in evaluation studies makes it difficult to compare and summarise the predictive ability of risk scores. Overall, CVD risk scores rank individuals reasonably accurately and are therefore useful in the management of diabetes with regard to targeting therapy to patients at highest risk. However, due to the uncertainty in estimation of true risk, care is needed when using scores to communicate absolute CVD risk to individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-009-1454-0

Cites

65 of 66 references verified1 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465 · cited 1×
“Type 2 diabetes is a strong risk factor for cardiovascular disease (CVD), with some studies suggesting that it confers an equivalent risk to having had a myocardial infarction [1, 2]. Multifactorial interventions, such as the Steno-2 study, have been effective in reducing the risk of non-fatal [3] and fatal CVD [ 4 ]…”
Background
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
(2003) · The Lancet · doi:10.1016/s0140-6736(03)13636-7 · Cited by 2,876
Cardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,156
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials
(1996) · The Lancet · doi:10.1016/s0140-6736(96)04292-4 · Cited by 1,564
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study
Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation
Pencina, M. J., & D’Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1802 · Cited by 1,442
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P. N., Larson, M. G., Tofler, G. H., Levy, D. A., Newton‐Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,337
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer.
Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780
Self-citation
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.
D’Agostino, R. B., Wolf, P. A., Belanger, A. J., & Kannel, W. B. (1994) · Stroke · doi:10.1161/01.str.25.1.40 · Cited by 714
Predictive accuracy of the Framingham coronary risk score in British men:prospective cohort study
Brindle, P. M., Emberson, J., Lampe, F. C., Walker, M., Whincup, P. H., Fahey, T. P., & Ebrahim, S. B. J. (2003) · BMJ · doi:10.1136/bmj.327.7426.1267 · Cited by 524
The effect of including C-reactive protein in cardiovascular risk prediction models for women
Cook, N. R., Buring, J. E., & Ridker, P. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00128 · Cited by 504
Heart Protection Study
Collins, R., Armitage, J., Parish, S., Sleight, P., & Peto, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12475-0 · Cited by 492
The Limitations of Risk Factors as Prognostic Tools
Ware, J. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068249 · Cited by 466
Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada
Marrugat, J., Solanas, P., D’Agostino, R. B., SULLIVAN, L. M., Ordovás, J. M., Cordón, F., Ramos, R., Sala, J., Masiá, R., Rohlfs, I., et al. (2003) · Revista Española de Cardiología · doi:10.1016/s0300-8932(03)76861-4 · Cited by 463
Type 2 Diabetes as a “Coronary Heart Disease Equivalent”
Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2901 · Cited by 452
Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review
Brindle, P., Beswick, A. D., Fahey, T. P., & Ebrahim, S. B. J. (2006) · Heart · doi:10.1136/hrt.2006.087932 · Cited by 450
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Ridker, P. M., Brown, N. J., Vaughan, D. E., Harrison, D. G., & Mehta, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000133444.17867.56 · Cited by 420
Untitled work
Kothari (2002) · doi:10.1161/01.str.0000020091.07144.c7 · Cited by 420
An Assessment of Incremental Coronary Risk Prediction Using C-Reactive Protein and Other Novel Risk Markers
Folsom, A. R., Chambless, L. E., Ballantyne, C. M., Coresh, J., HEISS, G. M., Wu, K. K., Boerwinkle, E., Mosley, T. H., Sorlie, P. D., Diao, G., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1368 · Cited by 357
When can a risk factor be used as a worthwhile screening test?
Wald, N., Hackshaw, A., & Frost, C. D. (1999) · BMJ · doi:10.1136/bmj.319.7224.1562 · Cited by 342
Estimation of time‐dependent area under the ROC curve for long‐term risk prediction
Chambless, L. E., & Diao, G. (2005) · Statistics in Medicine · doi:10.1002/sim.2299 · Cited by 320
A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation
Hardeman, W., Sutton, S., Griffin, S., Johnston, M., White, A., Wareham, N. J., & Kinmonth, A. L. (2005) · Health Education Research · doi:10.1093/her/cyh022 · Cited by 311
Self-citation
Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research
Marteau, T. M., & Weinman, J. A. (2005) · Social Science & Medicine · doi:10.1016/j.socscimed.2005.08.005 · Cited by 294
Prediction of first coronary events with the Framingham score: A systematic review
Eichler, K., Puhan, M. A., Steurer, J., & Bachmann, L. M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.02.027 · Cited by 219
Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial
Kinmonth, A.-L., Wareham, N. J., Hardeman, W., Sutton, S., Prevost, A. T., Fanshawe, T., Williams, K. M., Ekelund, U., Spiegelhalter, D., & Griffin, S. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60070-7 · Cited by 200
Self-citation
Framingham, SCORE, and DECODE Risk Equations Do Not Provide Reliable Cardiovascular Risk Estimates in Type 2 Diabetes
Coleman, R. L., Stevens, R., Retnakaran, R. R., & Holman, R. R. (2007) · Diabetes Care · doi:10.2337/dc06-1358 · Cited by 192
Risk Prediction of Cardiovascular Disease in Type 2 Diabetes
Cederholm, J., Eeg-Olofsson, K., Eliasson, B., Zethelius, B., Nilsson, P. M., Gudbjörnsdottir, S., & Register, O. B. O. T. S. N. D. (2008) · Diabetes Care · doi:10.2337/dc08-0662 · Cited by 173
Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study
Guzder, R., Gatling, W., Mullee, M., Mehta, R. L., & Byrne, C. D. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01494.x · Cited by 172
Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study
The DECODE Study Group, & on behalf of the European Diabetes Epidemiology Group (2004) · Diabetologia · doi:10.1007/s00125-004-1574-5 · Cited by 170
Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.
(1998) · Europe PMC (PubMed Central) · Cited by 143
Prediction of Coronary Heart Disease in Middle-Aged Adults With Diabetes
Folsom, A. R., Chambless, L. E., Duncan, B. B., Gilbert, A. C., Pankow, J. S., & the Atherosclerosis Risk in Communities Study Investigators (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2777 · Cited by 140
Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort
Simmons, R. K., Coleman, R. L., Price, H. C., Holman, R. R., Khaw, K., Wareham, N. J., & Griffin, S. J. (2008) · Diabetes Care · doi:10.2337/dc08-1918 · Cited by 140
Self-citation
Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada
Marrugat, J., Solanas, P., D’Agostino, R. B., et al. (2003) · Revista Española de Cardiología · doi:10.1157/13043951 · Cited by 137
Development and Validation of a Total Coronary Heart Disease Risk Score in Type 2 Diabetes Mellitus
Yang, X., So, W., Kong, A. P. S., Ronald, C. W., Ko, G. T. C., Ho, C. S., Lam, C. W. K., Cockram, C. S., Chan, J. C. N., & Tong, P. C. Y. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.10.019 · Cited by 119
Development and Validation of Stroke Risk Equation for Hong Kong Chinese Patients With Type 2 Diabetes
Yang, X., So, W., Kong, A. P. S., Ho, C. S., Lam, C. W. K., Stevens, R., Lyu, R., Yin, D., Cockram, C. S., Tong, P. C. Y., et al. (2006) · Diabetes Care · doi:10.2337/dc06-1273 · Cited by 118
A simple computer program for guiding management of cardiovascular risk factors and prescribing
Hingorani, A. D., & Vallance, P. J. (1999) · BMJ · doi:10.1136/bmj.318.7176.101 · Cited by 118
Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929)
Pepe, M. S., Feng, Z., & Gu, J. W. (2007) · Statistics in Medicine · doi:10.1002/sim.2991 · Cited by 105
Evaluating the performance of the Framingham risk equations in a population with diabetes
McEwan, P. C., Williams, J. E., Griffiths, J. D., Bagust, A., Peters, J. R., Hopkinson, P. K., & Currie, C. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01139.x · Cited by 91
Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?
Stephens, J. W., Ambler, G., Vallance, P. J., Betteridge, D. J., Humphries, S. E., & Hurel, S. J. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000136418.47640.bc · Cited by 89
Derivation and Validation of a Prediction Score for Major Coronary Heart Disease Events in a U.K. Type 2 Diabetic Population
Donnan, P. T., Donnelly, L. A., New, J. P., & Morris, A. D. (2006) · Diabetes Care · doi:10.2337/dc05-1911 · Cited by 85
A coronary primary prevention study of Scottish men aged 45?64 years: Trial design
(1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90068-x · Cited by 85
Covered Stent Septal Ablation for Hypertrophic Obstruction Cardiomyopathy
Anzuini, A., & Uretsky, B. F. (2004) · Circulation · doi:10.1161/01.cir.0000111127.49988.79 · Cited by 82
Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer–Norfolk Cohort Does Adding Glycated Hemoglobin Improve the Prediction of Coronary Heart Disease Events?
Simmons, R. K. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1209 · Cited by 75
Self-citation
Lipid-Lowering for Prevention of Coronary Heart Disease: What Policy Now?
Haq, I. U., Ramsay, L. E., Pickin, D. M., Yeo, W. W., Jackson, P., & Payne, J. N. (1996) · Clinical Science · doi:10.1042/cs0910399 · Cited by 74
Predicting CHD risk in patients with diabetes mellitus
Yeo, W. W., & Yeo, W. W. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00510.x · Cited by 61
How do people with Type 2 diabetes perceive and respond to cardiovascular risk?
Carroll, C., Naylor, E., Marsden, P. D., & Dornan, T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00910.x · Cited by 55
The decode study
Balkau, B. (2008) · Cited by 45
Predicting Cardiovascular Risk
Lloyd‐Jones, D. M., & Tian, L. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1342 · Cited by 33
Variabilidad en la estimación del riesgo coronario en la diabetes mellitus tipo 2
Mollet, J. J., Molist‐Brunet, N., Franch‐Nadal, J., Borraz, V. S., Barragán, L. S., & Giménez, R. G. (2005) · Atención Primaria · doi:10.1157/13071042 · Cited by 32
Prediction of cardiovascular risk in people with diabetes
Winocour, P. H., & Fisher, M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00934.x · Cited by 26
[Cardiovascular risk and diabetes].
Passa, P. (1998) · PubMed · Cited by 25
Comparative Study of Prognostic Value for Coronary Disease Risk Between the U.K. Prospective Diabetes Study and Framingham Models
Protopsaltis, I. D., Konstantinopoulos, P. A., Kamaratos, A. V., & Melidonis, A. I. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.277 · Cited by 21
The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 × 2 factorial understanding risk trial
Price, H. C., Tucker, L., Griffin, S. J., & Holman, R. R. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-21 · Cited by 19
Self-citation
Framingham risk equations underestimate coronary heart disease risk in diabetes
Stevens, R., Coleman, R. L., & Holman, R. R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01387.x · Cited by 15
La escala de Framingham sobrevalora el riesgo cerebrovascular de la diabetes y el síndrome metabólico en la población española
Costa, B., Cabré, J. J., Martín‐Luján, F., Piñol, J. L., Basora, J., & Bladé, J. (2005) · Atención Primaria · doi:10.1157/13074794 · Cited by 15
Importance of blood glucose management in the multifactorial approach of absolute cardiovascular risk in type 2 diabetes: the lessons from the Steno 2 Study
Raccah, D. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(06)70486-4 · Cited by 13

Flagged first, then by citations

Sorted by citations

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,994
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)
Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., Huikuri, H., et al. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes
Buijsse, B., Simmons, R. K., Griffin, S. J., & Schulze, M. B. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxq019 · Cited by 297
Self-citation

See all 176

Authors: Chamnan, P., Simmons, R. K., Sharp, S. J., Griffin, S. J., & Wareham, N. J.
Affiliations: Addenbrooke's Hospital (GB)
Corresponding author: Wareham, N. J.
ORCID: Chamnan, P.
Simmons, R. K.
Sharp, S. J.
Griffin, S. J.
Wareham, N. J.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2009-07-24
Volume: 52
Issue: 10
Pages: 2001-2014
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-009-1454-0
PMC: PMC2744770
OpenAlex: W1969752830
Cited by: 176
References: 66
Citations by year: 2026: 7 · 2025: 4 · 2024: 3 · 2023: 11 · 2022: 11 · 2021: 10 · 2020: 4 · 2019: 9 · 2018: 11 · 2017: 13 · 2016: 13 · 2015: 19 · 2014: 20 · 2013: 17 · 2012: 4
FWCI: 1.05
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: Diabetologia (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: University of Cambridge
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: cardiovascular risk score, type 2 diabetes, cardiovascular risk, risk prediction, risk score validation, risk score comparison, predictive performance, risk communication, diabetes management
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Risk Factors, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular risk assessment scores for people with diabetes: a systematic review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks